Novo Nordisk says up to 2022, it expects to hire 6,000 new employees in Denmark, half of whom will work within research and development. The company made the announcement in connection with an analysis it offered at a conference, Invitation to Growth–A Road to Job Creation, which the company held at is headquarters in Bagsværd, Denmark.

“With the expectation of creating 6,000 new jobs in Denmark over the coming years, it will be crucial for Novo Nordisk that Denmark educates world-class graduates but also focuses far more intently on attracting international talent,” said Novo Nordisk Executive Vice President and Chief Science Officer Mads Krogsgaard Thomsen, in a company statement. The company said the addition of its 6,000 jobs will have the derived effect of boosting employment by more than 15,000 jobs nationally.

Novo Nordisk offered an analysis on the value that can be created in the interaction between businesses and public-sector research and education as well as the challenges that must be solved so that research-based businesses can continue to grow in Denmark. The analysis presented new forecasts for the future availability of university graduates and PhDs and questions whether Denmark is investing sufficiently in the frameworks that are necessary for providing strong research-based degree. This issue was discussed at the conference, which includes other noteworthy speakers:Danish Minister for Higher Education and Science Sofie Carsten Nielsen; Chair of the Government's Expert Committee on Quality in Higher Education Jørgen Søndergaard; Rector of the University of Copenhagen Ralf Hemmingsen; and the political spokespersons for the Liberal Party of Denmark and the Danish Social Democrats.

Source: Novo Nordisk